Posted by Michael Wonder on 12 Apr 2021
ICER publishes research protocol for assessing the unsupported price increases on prescription drugs that occurred in 2020
12 April 2021 - Final assessment to be published on 16 November; through 10 May, ICER is accepting public Input on drugs of concern that should be considered in addition to those identified through the protocol’s selection criteria.
The Institute for Clinical and Economic Review today posted a protocol outlining how we will conduct our next analysis of “Unsupported Price Increases” among prescription drugs within the US market.
This initiative will examine the most significant drug-price increases that occurred in 2020 and determine whether new clinical evidence exists that could be used to support those increases.
